biOasis Technologies Ord Shs BIOAF

Highs, Trends and Nonsense

[Boomskid]

The current value of any trend is either the high of the trended period or is below the high of that period. In any given year, essentially all daily values of any trend are below that trend's high.

Using individual trend values, either the high or values that are off their highs to make the case for unrelated trends is totally unreliable and is often simple nonsense.

Any good or bad story that relates to a speculative stock will cause that stock's share price to buck any larger trend, including how the holy S&P Biotech EGF trends.

That's why people buy speculative stocks. They hope that the speculative stock's story will cause the stock's share price to go up faster than general and/or sector trends' average share prices go up.

There would be no junior markets without that real possibility.

jd

[prophetoffactz]

"Any good or bad story that relates to a speculative stock will cause that stock's share price to buck any larger trend, including how the holy S&P Biotech EGF trends." The market can be overwhelming. Check out the chart for ARRK. It invests in long term speculative assets in various industries. The big cashflow is way in the future. It is down about 75% in the last two years

[Boomskid]

Poof, we all know that Bioasis has earned its 1.5 cent share price. We know about debt. Rathjen essentially removed xB3 from the picture for the last 12 or 15 months, creating complete confusion for a market trying to figure out what Bioasis is worth. She entered a deals that are almost worthless. She replaced xB3 with Cresence EGF as the major Bioasis program. Midatech, through Ladenburg